Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
2017 · Science · 5,249 citations
https://doi.org/10.1126/science.aan3706
K
Kristina Iribarren
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
7.6K
Citations
20
h-index
24
i10-index
Kristina Iribarren is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune Response and Inflammation & Immune cells in cancer. The author has an h-index of 20, co-authored 30 publications.
ORCID: 0000-0002-2930-8573Papers by this author
worksImmunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
2020 · Nature Communications · 129 citations
https://doi.org/10.1038/s41467-020-17644-0
Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
2019 · Nature Communications · 13 citations
https://doi.org/10.1038/s41467-019-09838-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat